4//SEC Filing
Hubbard Cristin 4
Accession 0001048477-25-000053
CIK 0001048477other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 5:07 PM ET
Size
6.3 KB
Accession
0001048477-25-000053
Insider Transaction Report
Form 4
Hubbard Cristin
EVP, Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-05-02$64.92/sh−273$17,723→ 32,700 total - Award
Common Stock
2025-04-30$54.14/sh+273$14,779→ 32,973 total
Footnotes (2)
- [F1]Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan.
- [F2]Trade made pursuant to a 10b5-1 plan executed on September 13, 2024.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0002021836
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 5:07 PM ET
- Size
- 6.3 KB